Author at Microdose

Keith Fiveson

Keith W Fiveson, Veteran, Author of The Mindfulness Experience, 8 Strategies to Live Life Now, and Founder of the Work Mindfulness Institute. He offers Coaching and Contemplative Psychotherapy. He is an IPI /MAPS certified and trained Psychedelic-Assisted Therapy Provider (PATP) focused on Mindfulness-Based Interventions (MBIs)

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Industry

15 Dec 2023

Kanna: The Power of Plants for Conscious Evolution

In a recent interview with the Mindfulness Experience podcast, Keith Fiveson discussed the power of Kanna for conscious evolution....

By Keith Fiveson

Health & Wellness

7 Apr 2023

Healing With Psychedelics, Virtual Reality & Artificial Intelligence

“Set refers to the subject; setting is the session's environment....

By Keith Fiveson

Culture

10 Mar 2023

Death, Hope, and The Psychedelic Experience

This article looks at death and psychedelics, the use of chaplains, doulas, hospices, and retreats that offer entheogenic experiences in a bid to help ease the impact of death passage....

By Keith Fiveson

Culture

3 Mar 2023

Ancient Civilizations and The Psychedelic Experience

Ancient Civilizations and The Psychedelic Experience....

By Keith Fiveson

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture, Industry

6 Dec 2022

Wonderland Journal: A New Generation of Psychedelic Community & Technology

Keith Fiveson reflects on the Wonderland conference and how psychedelics may help to shape and improve our societies and technologies for the next few decades....

By Keith Fiveson

Culture

21 Oct 2022

Psychedelics and Religious Liberty in the United States

People are turning away from organized religion, seeking new ways to connect and get insight into spirituality — using psychedelics as part of their new religious or spiritual practice....

By Keith Fiveson

Culture

8 Sep 2022

The Medicalization of Sacred Plant Medicines

Like many, I’ve watched the recent resurgence of interest in psychedelics and welcomed it as a promising development in the mental health field....

By Keith Fiveson

Culture

2 Jun 2022

The Psychedelic Hero’s Journey

Psychedelics and the Hero's Journey are a tool for helping us to overcome challenges, to transform, and achieve our goals....

By Keith Fiveson

Science

18 May 2022

Psychedelics and Mindfulness: The Future of Mental Health?

A deeper look at t breathing with Mindfulness Based Interventions (MBIs), combined with psychedelics....

By Keith Fiveson

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts

Keith W Fiveson, Veteran, Author of The Mindfulness Experience, 8 Strategies to Live Life Now, and Founder of the Work Mindfulness Institute. He offers Coaching and Contemplative Psychotherapy. He is an IPI /MAPS certified and trained Psychedelic-Assisted Therapy Provider (PATP) focused on Mindfulness-Based Interventions (MBIs)

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads